Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT StudyElizabeth Bancroft, Apollonia T. Helderman-van den Enden, Elizabeth Page et al.|European Urology|2014Cited by 250
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth Page, Manuel R. Teixeira, Natalie Taylor et al.|European Urology|2019Cited by 239
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Rosalind A. Eeles, Emma Killick et al.|Familial Cancer|2017Cited by 68